Publications

Full list of peer-reviewed original research is here.

Other peer-reviewed publications

  1. Van Allen EM, Ryan CJ. Novel secondary hormonal therapy in advanced prostate cancer: an update. Curr Opin Urol. 2009 May; 19(3):315-21.
  2. Personalized Medicine in Castration-Resistant Prostate Cancer.  Urol Clin North Am. Urol Clin North Am. 2012 Nov; 39(4):483-90.
  3. Gagan J, Van Allen EM. Next-generation sequencing to guide cancer therapy. Genome Med. 2015 Jul 29;7(1):80.
 
Research Publications without Named Authorship

  1. Cancer Genome Atlas Network.* Genomic Classification of Cutaneous Melanoma. Cell. 2015 Jun 18;161(7):1681-96. (*member of the Cancer Genome Atlas Research Network for this project; the “Author Contributions” section at the end of the manuscript states. “The Cancer Genome Atlas Research Network contributed collectively to this study.”)
  2. Cancer Genome Atlas Network.* The Molecular Taxonomy of Primary Prostate Cacner. Cell. 2015 Nov 5;163(4):1011-25. (*member of the Cancer Genome Atlas Research Network for this project; the “Author Contributions” section at the end of the manuscript states. “The Cancer Genome Atlas Research Network contributed collectively to this study.”)
 
 
Non-peer Reviewed Publications
 
Reviews, Chapters, Monographs, and Editorials

  1. Van Allen EM. A role in transition. Ann Intern Med. 2009 Sep 15; 151(6):427-8.        
  2. Van Allen EM. One day later. Continuing psychological stress after a cardiac intensive care rotation. J Gen Intern Med. 2010 Aug; 25(8):882-3.
  3. Van Allen EM. The Paradox of Positive Thinking. J Clin Oncol. 2011 Jul 1;29(19):2730-1.
  4. Van Allen EM. A piece of my mind. Paracentesis by moonlight. JAMA. 2011 Apr 27; 305(16):1635-6.
  5. Van Allen EM.  A Common Language for Transformative Healthcare Networking. N Engl J Med [online]. April 16, 2012.  http://nejm200.nejm.org/essay/a-common-language-for-transformative-healthcare-networking/
  6. Van Allen EM. Higher Power. In: Tyler-Lloyd MD, ed. The Real Life of an Internist. New York: Kaplan Publishing, 2009. P. 23-28.
 
Letters to the Editor

  1. Van Allen EM, Kohlwes RJ. Comments on the recent clinical guidance statement on HIV screening. Ann Intern Med. 2009 Aug 18; 151(4):286; author reply 287.
  2. Van Allen EM, Garraway LA, Rosenberg JE. Re: Floris H. Groenendijk, Jeroen de Jong, Elizabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol.  2015 Aug;68(2):e31-2.